CHAT and Alzheimer disease: To investigate cholinergic dysfunction in a mouse model of AD, we first performed immunohistochemistry with an anti-ChAT antibody to identify cholinergic fibers in the hippocampi and the medial prefrontal cortex (mPFC), the two major regions of the brain that were projected from BFCNs (Ballinger et al., 2016).